{"id":132073,"date":"2024-01-02T12:46:15","date_gmt":"2024-01-02T12:46:15","guid":{"rendered":"https:\/\/dailytalks.org\/?p=132073"},"modified":"2024-01-02T12:46:15","modified_gmt":"2024-01-02T12:46:15","slug":"africa-first-african-manufactured-combination-therapy-for-seasonal-malaria-chemoprevention-receives-who-prequalification","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=132073","title":{"rendered":"Africa: First African-Manufactured Combination Therapy For Seasonal Malaria Chemoprevention Receives WHO Prequalification"},"content":{"rendered":"<p>Universal Corporation Ltd] Geneva and Kiambu &#8212; Universal Corporation Ltd (UCL), a Strides Pharma Science Limited (Strides) enterprise, with support from MMV, becomes the first African manufacturer to gain WHO prequalification for their sulfadoxine-pyrimethamine + amodiaquine product. Sulfadoxine-pyrimethamine + amodiaquine (SPAQ) is a combination drug used to prevent malaria in children living in areas of seasonal malaria transmission&#8230;<br \/><a href=\"https:\/\/allafrica.com\/stories\/202311060365.html\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Universal Corporation Ltd] Geneva and Kiambu &#8212; Universal Corporation Ltd (UCL), a Strides Pharma Science<\/p>\n","protected":false},"author":1,"featured_media":132074,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[40],"tags":[],"class_list":["post-132073","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-africa"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/01\/132073-africa-first-african-manufactured-combination-therapy-for-seasonal-malaria-chemoprevention6594059b01c20",664,664,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/01\/132073-africa-first-african-manufactured-combination-therapy-for-seasonal-malaria-chemoprevention6594059b01c20-150x150.",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/01\/132073-africa-first-african-manufactured-combination-therapy-for-seasonal-malaria-chemoprevention6594059b01c20-300x300.",300,300,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/01\/132073-africa-first-african-manufactured-combination-therapy-for-seasonal-malaria-chemoprevention6594059b01c20",640,640,false],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/01\/132073-africa-first-african-manufactured-combination-therapy-for-seasonal-malaria-chemoprevention6594059b01c20",640,640,false],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/01\/132073-africa-first-african-manufactured-combination-therapy-for-seasonal-malaria-chemoprevention6594059b01c20",664,664,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/01\/132073-africa-first-african-manufactured-combination-therapy-for-seasonal-malaria-chemoprevention6594059b01c20",664,664,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/01\/132073-africa-first-african-manufactured-combination-therapy-for-seasonal-malaria-chemoprevention6594059b01c20",664,664,false],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/01\/132073-africa-first-african-manufactured-combination-therapy-for-seasonal-malaria-chemoprevention6594059b01c20-664x575.",664,575,true],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/01\/132073-africa-first-african-manufactured-combination-therapy-for-seasonal-malaria-chemoprevention6594059b01c20-590x410.",590,410,true]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=40\" rel=\"category\">Africa<\/a>","tag_info":"Africa","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/132073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=132073"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/132073\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/132074"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=132073"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=132073"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=132073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}